Showing results (91-100 of 270) with videos related to
Sort By:
Pageof 27
Cancers|October 14, 2023
MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a TargetGianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, et al.Pharmacological Research|January 17, 2017
Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatmentAntonio Passaro, Elena Guerini-Rocco, Alessia Pochesci, et al.Cancers|August 29, 2024
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs"Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, et al.Future Oncology (London, England)|February 13, 2015
Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trialFilippo de Marinis, Alain Vergnenegre, Antonio Passaro, et al.Molecules (Basel, Switzerland)|June 27, 2025
HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs-A Long Way to the TopPamela Trillo Aliaga, Gianluca Spitaleri, Ilaria Attili, et al.Cancer Treatment Reviews|August 11, 2020
Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published dataAntonio Passaro, Ilaria Attili, Stefania Morganti, et al.ESMO Open|August 22, 2020
erbB in NSCLC as a molecular target: current evidences and future directionsMarzia Del Re, Federico Cucchiara, Iacopo Petrini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2021
Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 TrialXiuning Le, Robin Cornelissen, Marina Garassino, et al.Translational Lung Cancer Research|July 15, 2016
Prognostic value of lymph node ratio in patients with pathological N1 non-small cell lung cancer: a systematic review with meta-analysisQian Li, Ping Zhan, Dongmei Yuan, et al.JTO Clinical and Research Reports|November 25, 2021
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK AlterationsWhitney E Lewis, Lingzhi Hong, Frank E Mott, et al.Pageof 27